Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

How I Treat CLL in 2020: How Do Ibrutinib/Rituximab & Venetoclax/Obinutuzumab Combinations Affect PFS? What Parameters Should Be Used to Guide the Treatment?

200 views
September 28, 2020
Comments 0
Login to view comments. Click here to Login